In contrast, the 21.11 μM crescent-shaped giant CAML from the blood sample of the CTC-positive patient with carcinosarcoma (Figure 3F) had a disease of Grade 3, Stage IIIC1, presence of LVI, and 72% myometrial invasion. Here, CAMLG is linked to carcinosarcoma.